An Economic Analysis of Anemia Prevention during Infancy

Journal of Pediatrics

Volumn 154, Issue 1, 2009, Pages 44-49

  Shaker, Marcus ^a,b   Jenkins, Pamela ^a,b   Ullrich, Christina ^d   Brugnara, Carlo ^e   Nghiem, Bao Tram ^c   Bernstein, Henry ^a,e  

^a CHILDREN S HOSPITAL AT DARTMOUTH   (United States)

^b Dartmouth's Center for the Evaluative Clinical Sciences   (United States)

^c DARTMOUTH COLLEGE   (United States)

^d DANA FARBER CANCER INSTITUTE   (United States)

^e BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN; IRON;

ARTICLE; BLOOD CELL COUNT; COHORT ANALYSIS; COMPUTER SIMULATION; COST BENEFIT ANALYSIS; COST OF ILLNESS; DIAGNOSTIC ACCURACY; HEMOGLOBIN BLOOD LEVEL; HEMOGLOBIN DETERMINATION; INFANCY; IRON DEFICIENCY ANEMIA; IRON THERAPY; MATHEMATICAL MODEL; MONTE CARLO METHOD; PRIORITY JOURNAL; RETICULOCYTE HEMOGLOBIN CONTENT; SENSITIVITY ANALYSIS;

ANEMIA, IRON-DEFICIENCY; BLOOD CELL COUNT; COST OF ILLNESS; COST-BENEFIT ANALYSIS; ERYTHROCYTE INDICES; HEMOGLOBINS; HUMANS; INFANT; MARKOV CHAINS; RETICULOCYTES; UNITED STATES;

EID: 57249095881     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpeds.2008.06.038     Document Type: Article

References (22)

1. Looker A.C., Dallman P.R., Carroll M.D., Gunter E.W., and Johnson C.L. Prevalence of iron deficiency in the United States. JAMA 277 (1997) 973-976
2. Lozoff B., Brittenham G.M., Viteri F.E., Wolf A.W., and Urrutia J.J. Developmental deficits in iron-deficient infants: effects of age and severity of iron lack. J Pediatr 101 (1982) 948-952
3. Oski F.A., Honig A.S., Helu B., and Howanitz P. Effect of iron therapy on behavior performance in nonanemic, iron-deficient infants. Pediatrics 71 (1983) 877-880
4. Walter T., Kovalskys J., and Stekel A. Effect of mild iron deficiency on infant mental development scores. J Pediatr 102 (1983) 519-522
5. Halterman J.S., Kaczorowski J.M., Aligne C.A., Auinger P., and Szilagyi P.G. Iron deficiency and cognitive achievement among school-aged children and adolescents in the United States. Pediatrics 107 (2001) 1381-1386
6. Lozoff B., Jimenez E., and Wolf A.W. Long-term developmental outcome of infants with iron deficiency. N Engl J Med 325 (1991) 687-694
7. Lozoff B., Jimenez E., Hagen J., Mollen E., and Wolf A.W. Poorer behavioral and developmental outcome more than 10 years after treatment for iron deficiency in infancy. Pediatrics 105 (2000) E51
8. Walter T., De Andraca I., Chadud P., and Perales C.G. Iron deficiency anemia: adverse effects on infant psychomotor development. Pediatrics 84 (1989) 7-17
9. Lozoff B., De Andraca I., Castillo M., Smith J.B., Walter T., and Pino P. Behavioral and developmental effects of preventing iron-deficiency anemia in healthy full-term infants. Pediatrics 112 (2003) 846-854
10. Goodnough L.T., Skikne B., and Brugnara C. Erythropoietin, iron, and erythropoiesis. Blood 96 (2000) 823-833
11. Major A., Mathez-Loic F., Rohling R., Gautschi K., and Brugnara C. The effect of intravenous iron on the reticulocyte response to recombinant human erythropoietin. Br J Haematol 98 (1997) 292-294
12. Brugnara C., Laufer M.R., Friedman A.J., Bridges K., and Platt O. Reticulocyte hemoglobin content (CHr): early indicator of iron deficiency and response to therapy. Blood 83 (1994) 3100-3101
13. Ullrich C., Wu A., Armsby C., Rieber S., Wingerter S., Brugnara C., et al. Screening healthy infants for iron deficiency using reticulocyte hemoglobin content. JAMA 294 (2005) 924-930
14. Hunink M.G. Decision Making in Health and Medicine: integrating evidence and values (2004), University Press, Cambridge, United Kingdom
15. Centers for Medicare and Medicaid Services. www.cms.hhs.gov Accessed 1/28/2007
16. Bureau of Labor Statistics. http://www.bls.gov/ Last accessed 3/10/06
17. Bogen D.L., Krause J.P., and Serwint J.R. Outcome of children identified as anemic by routine screening in an inner-city clinic. Arch Pediatr Adolesc Med 155 (2001) 366-371
18. Doctor's Office and Emergency Department Visits. http://www.dhmc.org/webpage.cfm?site_id=2&org_id=564&morg_id=0&sec_id=0&gsec_id=29698&item_id=29698 Accessed 3/25/2008
19. Biondich P.G., Downs S.M., Caroll A.E., Laskey A.L., Liu G.C., Rosenman M., et al. Shortcoming in infant iron deficiency screening methods. Pediatrics 117 (2006) 290-294
20. Prosser L.A., Ray G.T., O'Brien M., Kleinman K., Santoli J., and Lieu T.A. Preferences and willingness to pay for health states prevented by pneumococcal conjugate vaccine. Pediatrics 113 (2004) 283-290
21. Prosser L.A., Bridges C.B., Uyeki T.M., Rego V.H., Ray G.T., Meltzer M.I., et al. Values for preventing influenza-related morbidity and vaccine adverse events in children. Health Qual Life Outcomes 3 (2005) 18
22. Ortega A., Dranitsaris G., and Puodziunas A.L. What are cancer patients willing to pay for prophylactic epoetin alfa?. A cost-benefit analysis. Cancer 83 (1998) 2588-2596